Vinpocetine shows promise for chronic inflammation

Findings reported in article published online on May 6, 2010 in the Proceedings of the National Academy of Sciences (see link below) suggest that vinpocetine, a derivative of vincamine (from the periwinkle plant), could be useful for the treatment of chronic inflammatory diseases such as atherosclerosis, chronic obstructive pulmonary disease (COPD), arthritis, infectious diseases and cancer.

Researchers believe that  vinpocetine, which, according to wikipedia is a “semi-synthetic”  derivative of an extract of periwinkle, vincamine, could be very helpful for treating diseases connected to chronic inflammation. These include coronary artery disease, chronic obsstructive pulmonary disease, arthritis and rheumatoid arthritis, cancer, and a number of infectious diseases.

Because conditions such as macular edema and diabetic retinopathy are tied to inflammation, this derivative may be helpful for these conditions.

Published: Proceedings of the National Academy of Sciences, May 6, 2010.